Whalegun
Home

Neurocrine Biosciences NBIX paid Tarplin, Downs & Young $80K for lobbying in Q1 2024 · Health Issues

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q1 2024
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
24/04/16

Up 0.0% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/03/01~24/04/30

Neurocrine Biosciences's other lobbying reports

Neurocrine Biosciences NBIX paid Tarplin, Downs & Young $80K for lobbying in Q1 2024 · Health Issues | Whalegun